NephRx Corp. Awarded U.S. Patent for NX002 for Treatment of Oral Mucositis Second Patent Highlights Potential Broad Utility of Novel Growth Factor Peptide NX002 for Treatment of Oral Mucositis and Other GI Disorders Initiation of Detailed Toxicology Studies Targeted for...